<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03515642</url>
  </required_header>
  <id_info>
    <org_study_id>DVO005-1-338-CEI882</org_study_id>
    <nct_id>NCT03515642</nct_id>
  </id_info>
  <brief_title>Exercise, Gut Microbiota in Sedentary Adults With Overweight</brief_title>
  <official_title>Effect of Two Exercise Programme on Gut Microbiota, Hepatic Metabolism and Adipokines in Sedentary Adults With Overweight</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Santo Tomas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad de Santiago de Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universidad PÃºblica de Navarra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universidad del Rosario</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NavarraBiomed Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Santo Tomas</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project offers the opportunity to obtain detailed measurements on the health of body
      composition, metabolic health, and intestinal microbial diversity in overweight adults;
      moreover to provide information about the effects of physical exercise on them. The aim of
      the research is to advance in the understanding of the mechanisms induced by physical
      exercise, which includes the measurement of nutritional parameters, clinical and biochemical
      biomarkers of hepatic/cardiometabolic health, as well as the application of differential
      proteomics technologies by means of Arrays of cytokines and intestinal microbiome, making
      this study a novel and pioneer in sensitive areas of primary health care in Latin America.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2018</start_date>
  <completion_date type="Anticipated">August 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gut microbiota</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline in the gut microbiota composition measured by amplicon sequencing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma metabolomic profile</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline in the metabolomic profile will be also evaluated by a HPLC-MS approach</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma hepatokines</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline in the Chemerin will be measured using ELISA kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma hepatokines</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline in the Selenoprotein P will be measured using ELISA kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma hepatokines</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline in the Fetuin-A will be measured using ELISA kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma hepatokines</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline in the FGF21 (fibroblast growth factor 21) Leukocyte cell-derived will be measured using ELISA kits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline will be also evaluated by a spectroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline will be also evaluated by a ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated hemoglobin</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline will be also evaluated by a ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bioinflammatory blood markers</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline measure of plasma IL-1 concentrations measured ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bioinflammatory blood markers</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline measure of plasma IL6 concentrations measured ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bioinflammatory blood markers</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline measure of plasma TNF-alfa concentrations measured ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bioinflammatory blood markers</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Change from Baseline measure of plasma CRP concentrations measured ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Differences in body weight (kilograms) measured by DXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Differences in body fat (%) measured by DXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Differences in mass muscle measured by DXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical fitness</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Differences in Muscular strength (handgrip test) in kg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical fitness</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Differences in Maximum Oxygen Consumption (VO2 max K5 Gas Analyser) in ml/kg/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy substrate oxidation</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Fat and carbohydrate oxidation in the fasted and postprandial state measured before and after the interventions using indirect calorimetry (K5 cosmed)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Metabolic Rate</measure>
    <time_frame>Baseline, and 6 weeks immediately after the interventions ends</time_frame>
    <description>Resting metabolic rate was measured before and after the interventions (K5 Cosmed)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Metabolic Disturbance</condition>
  <arm_group>
    <arm_group_label>HIIT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The HIIT modality consisted of 30-40 minutes (min) of steady-state, high-intensity training 3 d/wk on a stationary bicycle at the target heart rate (HR) range equivalent to 85% to 95% of the individual's maximum oxygen consumption rate (VO2max). Exercise will be performed at three sessions per week. All sessions will be supervised by an exercise physiologist during 6-weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SIT group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The SIT modality consisted of 6 to 10 repetitions of a 30 s segment of all-out exercise interspersed with 2 min of recovery, 3 d/wk on a stationary bicycle at the target heart rate (HR) range equivalent to 90% to 95% of the individual's maximum oxygen consumption rate (VO2max).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIIT group</intervention_name>
    <description>Physical Training</description>
    <arm_group_label>HIIT group</arm_group_label>
    <arm_group_label>SIT group</arm_group_label>
    <other_name>High/low volume exercise</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Sedentary males

          -  BMI&gt;25 kg/m2, on a stable body weight for the last 3 months

        Exclusion Criteria:

          -  Acute or chronic illness

          -  Use of antibiotics the past 2 months

          -  Smoking
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Robinson RamÃ­rez-VÃ©lez, PhD</last_name>
    <phone>+57 (1) 2970200</phone>
    <phone_ext>3428</phone_ext>
    <email>robin640@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jorge E Correa-Bautista, PhD</last_name>
    <phone>+57 (1) 2970200</phone>
    <phone_ext>3428</phone_ext>
    <email>jorge.correa@urosario.edu.co</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Robinson RamÃ­rez-VÃ©lez</name>
      <address>
        <city>BogotÃ¡</city>
        <state>Cundinamarca</state>
        <zip>111221</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robinson RamÃ­rez-VÃ©lez, Ph.D</last_name>
      <phone>+57 (1) 2970200</phone>
      <email>robin640@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jorge E Correa-Bautista, Ph.D</last_name>
      <phone>+57 (1) 2970200</phone>
      <email>jorge.correa@urosario.edu.co</email>
    </contact_backup>
    <investigator>
      <last_name>Viviana Aya, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mikel Izquierdo, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan D RamÃ­rez, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Barajas, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JoaquÃ­n FernÃ¡ndez-Irigoyen, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Enrique SantamarÃ­a, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge E Correa-Bautista, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robinson RamÃ­rez-VÃ©lez, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2018</study_first_submitted>
  <study_first_submitted_qc>May 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2018</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gut microbiota</keyword>
  <keyword>Hepatic function</keyword>
  <keyword>Obesity</keyword>
  <keyword>Exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

